Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung

Keyphrases

• Pathologic Analysis 100%
• Lung Large Cell Neuroendocrine Carcinoma (L-LCNEC) 100%
• Large Cell Neuroendocrine Carcinoma (LCNEC) 100%
• Resection 66%
• 5-year Survival 66%
• Poor Prognosis 33%
• Radiation Therapy 33%
• Cancer Treatment 33%
• Lung Cancer 33%
• Stage Distribution 33%
• Poor Differentiation 33%
• Adjuvant Therapy 33%
• University of Washington 33%
• Appropriate Treatment 33%
• Early Disease 33%
• Preoperative Chemotherapy 33%
• Referring Physician 33%
• Histologic Examination 33%
• Mixed Cell 33%
• Stage I Disease 33%
• Patient Charts 33%
• Small Cell 33%
• Neuroendocrine Differentiation 33%
• High-grade Lesion 33%
• No Evidence of Disease 33%
• Classification Identification 33%
• Classification Treatment 33%
• Atypical Carcinoid 33%
• Postoperative Intervention 33%
• Pulmonary Carcinoma 33%

Medicine and Dentistry

• Large Cell Neuroendocrine Carcinoma 100%
• Lung 100%
• Diseases 100%
• Cancer Therapy 14%
• Lung Cancer 14%
• Adjuvant Therapy 14%
• Lung Carcinoma 14%
• Carcinoid 14%
• Neuroendocrine Differentiation 14%
• Radiation Therapy 14%
• Stage Distribution 14%
• Referring Physician 14%